Disposition of 2485 shares by Daniel Ackerman of AptarGroup at 141.0 subject to Rule 16b-3
| ATR Stock | USD 155.50 1.34 0.87% |
Slightly above 51% of AptarGroup's investor base is interested to short. The analysis of overall sentiment of trading AptarGroup stock suggests that many investors are impartial at this time. AptarGroup's investing sentiment overview a quick insight into current market opportunities from investing in AptarGroup. Many technical investors use AptarGroup stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
AptarGroup |
Filed transaction by AptarGroup Officer: Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at finance.yahoo.com
 |
AptarGroup Fundamental Analysis
We analyze AptarGroup's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AptarGroup using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AptarGroup based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
AptarGroup is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
AptarGroup Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AptarGroup stock to make a market-neutral strategy. Peer analysis of AptarGroup could also be used in its relative valuation, which is a method of valuing AptarGroup by comparing valuation metrics with similar companies.
Peers
AptarGroup Related Equities
| AKYA | Akoya Biosciences | 6.11 | ||||
| ATRC | AtriCure | 5.36 | ||||
| WST | West Pharmaceutical | 2.18 | ||||
| HAE | Haemonetics | 2.10 | ||||
| TFX | Teleflex Incorporated | 1.51 | ||||
| ICUI | ICU Medical | 1.41 | ||||
| RMD | ResMed | 1.40 | ||||
| COO | Cooper Companies, | 1.25 | ||||
| ANGO | AngioDynamics | 1.11 | ||||
| ALC | Alcon AG | 0.73 | ||||
| MMSI | Merit Medical | 0.19 | ||||
| NVST | Envista Holdings | 0.42 |
Additional Tools for AptarGroup Stock Analysis
When running AptarGroup's price analysis, check to measure AptarGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptarGroup is operating at the current time. Most of AptarGroup's value examination focuses on studying past and present price action to predict the probability of AptarGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptarGroup's price. Additionally, you may evaluate how the addition of AptarGroup to your portfolios can decrease your overall portfolio volatility.